Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (£272m) over five years due to Washington's request for sensitive biological samples.
This rejection came to light following a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the agreement was "skewed".
An official representative has since explained that the United States was requesting health data for scientific study and commercial gain but was not willing to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for further talks to reach a deal acceptable to both sides so the country's vital HIV programme can proceed.
Wider Implications
This development comes after a similar situation in neighbouring Kenya, where a high court blocked a related deal with the US after legal challenges were filed about the security of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.
According to reports, 16 nations in Africa have to date agreed to similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Effectively, our nation would supply the raw materials for medical research with no certainty that the final treatments would be available to our citizens should a new disease outbreak emerge."
Sovereignty and Global Health
He also noted that the American exit from the global health body and its pursuit of bilateral deals were undermining structures previously set up via the global organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This system is intended to guarantee that when a country provides its data, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent collaboration could be designed in a way that respects the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that talks need to persist since a large portion of the nation's HIV programmes were funded by external financing.
"Where specific concerns exist, such as those involving information security or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group added.
The halted deal underscores the ongoing tensions between accepting much-needed foreign assistance and safeguarding local interests in an increasingly interconnected world.